Recent Finacing
Recent Raise
ALZpath develops diagnostic assays for Alzheimer’s disease centered on ALZpathDx, a pTau217 quantification assay available as a Quanterix RUO kit and lab service, pursuing analytical/clinical validation and LDT launch.
Focus Areas
Recent Investors
Funding round
Investor